These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16778321)

  • 1. Leishmaniasis vaccine candidates for development: a global overview.
    Khamesipour A; Rafati S; Davoudi N; Maboudi F; Modabber F
    Indian J Med Res; 2006 Mar; 123(3):423-38. PubMed ID: 16778321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically modified live attenuated parasites as vaccines for leishmaniasis.
    Selvapandiyan A; Duncan R; Debrabant A; Lee N; Sreenivas G; Salotra P; Nakhasi HL
    Indian J Med Res; 2006 Mar; 123(3):455-66. PubMed ID: 16778323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunology of Leishmania infection and the implications for vaccine development.
    Vanloubbeeck Y; Jones DE
    Ann N Y Acad Sci; 2004 Oct; 1026():267-72. PubMed ID: 15604504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmaniasis.
    Kedzierski L
    Hum Vaccin; 2011 Nov; 7(11):1204-14. PubMed ID: 22048116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-generation vaccines against leishmaniasis.
    Coler RN; Reed SG
    Trends Parasitol; 2005 May; 21(5):244-9. PubMed ID: 15837614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress towards a Leishmania vaccine.
    Tabbara KS
    Saudi Med J; 2006 Jul; 27(7):942-50. PubMed ID: 16830009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC; Yang J; Zhao W; Perez LE; Cheng J
    Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmaniasis vaccines: past, present and future.
    Modabber F
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S58-61. PubMed ID: 20801000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Approaches and problems in vaccine development against leishmaniasis].
    Allahverdiyev A; Bağirova M; Cakir Koç R; Oztel ON; Elçıçek S; Ateş SC; Karaca TD
    Turkiye Parazitol Derg; 2010; 34(2):122-30. PubMed ID: 20597059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine candidates for leishmaniasis: a review.
    Nagill R; Kaur S
    Int Immunopharmacol; 2011 Oct; 11(10):1464-88. PubMed ID: 21616175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present status of antileishmanial vaccines.
    Ghosh M; Bandyopadhyay S
    Mol Cell Biochem; 2003 Nov; 253(1-2):199-205. PubMed ID: 14619970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania vaccines: progress and problems.
    Kedzierski L; Zhu Y; Handman E
    Parasitology; 2006; 133 Suppl():S87-112. PubMed ID: 17274851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines for leishmaniasis in the fore coming 25 years.
    Palatnik-de-Sousa CB
    Vaccine; 2008 Mar; 26(14):1709-24. PubMed ID: 18295939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
    Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possibilities and challenges for developing a successful vaccine for leishmaniasis.
    Srivastava S; Shankar P; Mishra J; Singh S
    Parasit Vectors; 2016 May; 9(1):277. PubMed ID: 27175732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in vaccines for leishmaniasis.
    Requena JM; Iborra S; Carrión J; Alonso C; Soto M
    Expert Opin Biol Ther; 2004 Sep; 4(9):1505-17. PubMed ID: 15335317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmaniasis: current status of vaccine development.
    Handman E
    Clin Microbiol Rev; 2001 Apr; 14(2):229-43. PubMed ID: 11292637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
    Ahmed SB; Touihri L; Chtourou Y; Dellagi K; Bahloul C
    Vaccine; 2009 Jan; 27(1):99-106. PubMed ID: 18951941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status and perspectives of the immunotherapy of leishmaniasis.
    El-On J
    Isr Med Assoc J; 2009 Oct; 11(10):623-8. PubMed ID: 20077951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.